Sun Pharma

Sun Pharma to Acquire Checkpoint Therapeutics

Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The transaction is expected to be completed in the second quarter of 2025 and is subject to customary closing conditions.

News

India's Sun Pharma, US Merck in Generics Joint Venture

Top-Feature

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Brenntag SE

Brenntag Downsizes Management Board, Retains Both Divisions

Dow Chemical Company

Anchored in Sustainability

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Sasol

Leading Transformation

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

Together for Sustanability (TFS)

Driving Sustainability Through Collaboration

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.